Effect of probiotics on colorectal cancer in clinical trials

ABSTRACT: Interventions: Ten subjects receive probiotic product contained 10 million CFU in viable form 3 times a day for 6 months,Ten subjects receive probiotic product contained 10 million CFU in non viable form 3 times a day for 6 months, Ten subjects receive product without probiotic 3 times a day for 6 months;Active Comparator Dietary Supplement,Active Comparator Dietary Supplement,Placebo Comparator Dietary Supplement;probiotic products in viable form,probiotic products in non viable form,Control Primary outcome(s): reduceing of number of pathogens in gut at 6 months after intervention number of pathogens / Anova Study Design: Randomized

DISEASE(S): Probiotics, Colorectal Cancer, Butyrate, Anti-inflammation, Stimulating Immune,Colorectal Cancer Is The Third Most Prevalent Cause Of Death Among The Different Types Of Cancer Worldwide- Imbalance Of Microorganisms In Gut Causes Colorectal Cancer- Probiotic Strains Can Help To Balance Of Microorganisms In Gut

PROVIDER: 2727906 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR